A tiny ayahuasca case series suggested PTSD benefit in combat veterans — but a correction lowered the numbers
An observational case series studied eight combat veterans who took part in a three-day ayahuasca intervention — and a later published correction clarified their PTSD symptoms were moderate, not clinical.
This small mixed-methods case series studied eight combat veterans who took part in a three-day ayahuasca intervention, measuring PTSD symptoms before, after, and at three months. Most showed a reliable improvement, with a majority holding it at three months, and some reported difficult experiences during the sessions. Two important caveats sit up front: it was an observational study with no comparison group, and a 2024 published correction revised the study's figures downward and clarified that the participants had moderate — not clinical — PTSD symptoms. It's a preliminary signal, not trial-grade evidence.
This convergent mixed-methods case series studied eight military combat veterans who participated in a three-day ayahuasca intervention, assessing PTSD (PCL-5), experience-sampled momentary symptoms, and open-ended perceived benefits before, immediately after, and at three months. The majority showed reliable and/or clinically significant PCL-5 change post-treatment, maintained by a majority at three months; adverse acute experiences were reported.
Two limitations are central and were foregrounded here. First, this is a very small (n=8), observational case series with no control group — it cannot establish efficacy. Second, a 2024 published correction revised the analysis: a scoring error had overstated symptom severity, and the corrected data reflect moderate (not clinical) PTSD, with the reliable-change estimate reduced (from 87.5% to 71.4%). Adverse acute experiences during sessions were also reported. The findings are preliminary.
It adds to naturalistic and observational reports of ayahuasca for trauma in veterans, including retreat-based studies where ayahuasca showed the greatest PTSD improvement among psychedelics assessed (Calnan et al., 2025). No controlled trial of ayahuasca for PTSD in veterans has yet been published.
Read the full paper →